Private-equity firm Carlyle Group is in exclusive talks to acquire medical-device maker Baxter’s kidney-care spinoff Vantive for more $4 billion, including debt.
Read Also
- ‘What are we going to do about it?’: Manitoba stakeholders attend retail crime summit
- Shock in French Court Shown Videos of Men Accused of Raping Drugged Woman
- Shaping Saskatchewan: Allan Kehler
- ‘No one will vote for her’: Kamala Harris faces challenges in gaining back Arab American and Muslim support
- This Alberta teacher spent 1,800 hours over 1 year building a homemade hovercraft from scratch
- ‘She should still be here’: Family calls for justice in wake of N.S. woman’s death
- Creepy, buried rug sets off viral firestorm, people convinced it’s a dead body
- Georgia businessman convicted of cheating two ex-NBA players of $8M
- Biden issues terse words to Netanyahu over peace deal and election influence
- More than 30% of people who drive on Edmonton roads don’t live in the city: report
Latest The Wall Street Journal
- Dikembe Mutombo, NBA Star Known for his Height and Heart, Dies at 58
- At Least 70 Dead After Gang Attack in Haiti
- Iranian Missiles Overwhelmed Israeli Defenses at Some Sites, Analysts Say
- Israeli Bombardment Targets Expected Hezbollah Successor in Beirut
- Nightmares of a Chinese Invasion Inspire Taboo-Breaking Entertainment in Taiwan
- Biden Sidelined as Israel Reshapes Middle East
- Key U.S. Military Base Secured as U.K. Returns Disputed Islands to Mauritius
- Israel's Invasion Gamble Risks a Quagmire in Lebanon
- Israel Strikes in Beirut, Battles Hezbollah in Southern Lebanon
- China's Patriotic Rhetoric Takes a Violent Turn